BFA
RCKT icon

BlackRock Fund Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

BlackRock Fund Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.37M Sell
138,018
-70,859
-34% -$2.02M ﹤0.01% 3052
2016
Q3 		$7.92M Buy
208,877
+11,798
+6% +$371K ﹤0.01% 2596
2016
Q2 		$5.87M Buy
197,079
+107,176
+119% +$3.77M ﹤0.01% 2701
2016
Q1 		$2.66M Buy
89,903
+8,248
+10% +$247K ﹤0.01% 2994
2015
Q4 		$3.7M Buy
81,655
+77,468
+1,850% +$3.38M ﹤0.01% 2980
2015
Q3 		$157K Buy
+4,187
New +$192K ﹤0.01% 3572

Other funds holding RCKT

RCP
Rho Capital Partners New York $20.4M AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return